{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:24:44Z","timestamp":1649121884721},"reference-count":44,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2020.11505","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T08:58:55Z","timestamp":1585817935000},"source":"Crossref","is-referenced-by-count":0,"title":["Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma"],"prefix":"10.3892","author":[{"given":"Guozun","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong\u2011Liang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Cangzhou Medical College, Cangzhou, Hebei 061001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"key":"key20220302131349_b1-ol-0-0-11505","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"Van Zandwijk","year":"2013","journal-title":"J Thorac Dis"},{"key":"key20220302131349_b2-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.humpath.2018.07.003","article-title":"IMP3 as a prognostic biomarker in patients with malignant peritoneal mesothelioma","volume":"81","author":"Hui","year":"2018","journal-title":"Hum Pathol"},{"key":"key20220302131349_b3-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"key":"key20220302131349_b4-ol-0-0-11505","first-page":"867","article-title":"Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67","volume":"138","author":"Gerdes","year":"1991","journal-title":"Am J Pathol"},{"key":"key20220302131349_b5-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1200\/JCO.2010.31.2835","article-title":"Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer","volume":"29","author":"Cuzick","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20220302131349_b6-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1471-2407-6-203","article-title":"Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer","volume":"6","author":"Yang","year":"2006","journal-title":"BMC Cancer"},{"key":"key20220302131349_b7-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/ijc.24174","article-title":"Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer","volume":"124","author":"Zellweger","year":"2009","journal-title":"Int J Cancer"},{"key":"key20220302131349_b8-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/bjc.2015.9","article-title":"Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: A multicenter study","volume":"112","author":"Ghanim","year":"2015","journal-title":"Br J Cancer"},{"key":"key20220302131349_b9-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-016-0313-3","article-title":"CD146 promotes metastasis and predicts poor prognosis of hepatocellularcarcinoma","volume":"35","author":"Jiang","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"key20220302131349_b10-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12935-014-0147-z","article-title":"The multifaceted role of CD146\/MCAM in the promotion of melanoma progression","volume":"15","author":"Lei","year":"2015","journal-title":"Cancer Cell Int"},{"key":"key20220302131349_b11-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13277-011-0260-8","article-title":"Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis and poor-prognosis related markers for gallbladder adenocarcinoma","volume":"33","author":"Wang","year":"2012","journal-title":"Tumour Biol"},{"key":"key20220302131349_b12-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/modpathol.2010.134","article-title":"Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium","volume":"23","author":"Sato","year":"2010","journal-title":"Mod Pathol"},{"key":"key20220302131349_b13-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/cas.12185","article-title":"CD146 and insulin-like growth factor 2 mRNA-binding protein 3 predict prognosis of asbestos-induced rat mesothelioma","volume":"104","author":"Okazaki","year":"2013","journal-title":"Cancer Sci"},{"key":"key20220302131349_b14-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"316739","DOI":"10.1155\/2015\/316739","article-title":"Serum surviving levels and outcome of chemotherapy in patients with maligna-nt mesothelioma","volume":"2015","author":"Gori\u010dar","year":"2015","journal-title":"Dis Markers"},{"key":"key20220302131349_b15-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1158\/1078-0432.CCR-08-0746","article-title":"Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics","volume":"15","author":"Mita","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20220302131349_b16-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/eci.12895","article-title":"Survivin is a negative prognostic factor in malignant pleural effusion","volume":"48","author":"Arellano-Orden","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"key20220302131349_b17-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"S719","DOI":"10.4103\/0973-1482.187346","article-title":"Survivinn expression as an independent predictor of overall survival in pancreatic adenocarcinoma","volume":"14","author":"Contis","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"key20220302131349_b18-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/path.2121","article-title":"Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma","volume":"211","author":"Gordon","year":"2007","journal-title":"J Pathol"},{"key":"key20220302131349_b19-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the international mesothelioma interest group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"key20220302131349_b20-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/cncr.25640","article-title":"A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database","volume":"117","author":"Yan","year":"2011","journal-title":"Cancer"},{"key":"key20220302131349_b21-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.athoracsur.2016.08.063","article-title":"Amount of epithelioid differentiation is a predictor of survival in malignant pleural mesothelioma","volume":"103","author":"Vigneswaran","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"key20220302131349_b22-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12957-018-1350-5","article-title":"Analysis of prognostic factors of patients with malignant peritoneal mesothelioma","volume":"16","author":"Yin","year":"2018","journal-title":"World J Surg Oncol"},{"key":"key20220302131349_b23-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1245\/s10434-013-3077-4","article-title":"Malignant peritoneal mesothelioma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Is GLUT1 expression a major prognostic factor? A preliminary study","volume":"20","author":"Hommell-Fontaine","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"key20220302131349_b24-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1245\/s10434-018-6499-1","article-title":"Malignant peritoneal mesothelioma: National practice patterns, outcomes, and predictors of survival","volume":"25","author":"Verma","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"key20220302131349_b25-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"2782590","DOI":"10.1155\/2017\/2782590","article-title":"Life expectancy in pleural and peritoneal mesothelioma","volume":"2017","author":"Shavelle","year":"2017","journal-title":"Lung Cancer Int"},{"key":"key20220302131349_b26-ol-0-0-11505","first-page":"10","article-title":"Two-Stage cytoreductive surgery and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Predictors of overall survival in an intention-to-treat series","volume":"12","author":"Leinwand","year":"2019","journal-title":"Ann Surg Oncol Dec"},{"key":"key20220302131349_b27-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","article-title":"Malignant peritoneal mesothelioma: Prognostic factors and oncologic outcome analysis","volume":"21","author":"Magge","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"key20220302131349_b28-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1245\/s10434-018-6385-x","article-title":"The c-reactive protein\/albumin ratio is a novel significant prognostic factor in patients with malignant pleural mesothelioma: A retrospective multi-institutional study","volume":"25","author":"Takamori","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"key20220302131349_b29-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: A systematic review and meta-analysis","volume":"22","author":"Helm","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"key20220302131349_b30-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"333","DOI":"10.14735\/amko2019333","article-title":"Treatment of malignant peritoneal mesothelioma","volume":"32","author":"Lev\u00fd","year":"2019","journal-title":"Klin Onkol"},{"key":"key20220302131349_b31-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","article-title":"Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy","volume":"21","author":"Feldman","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20220302131349_b32-ol-0-0-11505","first-page":"411","article-title":"Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma","volume":"3","author":"Pillai","year":"2013","journal-title":"Am J Cancer Res"},{"key":"key20220302131349_b33-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1073\/pnas.1111053108","article-title":"CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer","volume":"109","author":"Zeng","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20220302131349_b34-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/jcp.21341","article-title":"Blockade of adhesion molecule CD146 causes pregnancy failure in mice","volume":"215","author":"Liu","year":"2008","journal-title":"J Cell Physiol"},{"key":"key20220302131349_b35-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-08-1363","article-title":"Identification of MCAM\/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma","volume":"69","author":"Bidlingmaier","year":"2009","journal-title":"Cancer Res"},{"key":"key20220302131349_b36-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12032-014-0167-5","article-title":"Expression of serum survivin protein in diagnosis and prognosis of gallbladder cancer: A comparative study","volume":"31","author":"Nigam","year":"2014","journal-title":"Med Oncol"},{"key":"key20220302131349_b37-ol-0-0-11505","first-page":"3063","article-title":"Clinical significance of serum survivin in patients with pancreatic ductal adenocarcinoma","volume":"18","author":"Ren","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20220302131349_b38-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.molonc.2016.06.005","article-title":"Low merlin expression and high survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma","volume":"10","author":"Meerang","year":"2016","journal-title":"Mol Oncol"},{"key":"key20220302131349_b39-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00432-011-1030-0","article-title":"BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients","volume":"137","author":"Hmeljak","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20220302131349_b40-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.humpath.2006.12.013","article-title":"Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma","volume":"38","author":"Kleinberg","year":"2007","journal-title":"Hum Pathol"},{"key":"key20220302131349_b41-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"13119","DOI":"10.18632\/oncotarget.3761","article-title":"Anti-Tumor activity of selective inhibitors of XPO1\/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: The role of survivin","volume":"6","author":"De Cesare","year":"2015","journal-title":"Oncotarget"},{"key":"key20220302131349_b42-ol-0-0-11505","first-page":"453","article-title":"Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma","volume":"29","author":"Zaffaroni","year":"2007","journal-title":"Cell Oncol"},{"key":"key20220302131349_b43-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/JTO.0000000000000055","article-title":"PI3K\/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy","volume":"9","author":"Bitanihirwe","year":"2014","journal-title":"J Thorac Oncol"},{"key":"key20220302131349_b44-ol-0-0-11505","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00428-013-1373-9","article-title":"Is survivin expression prognostic or predictive in malignant pleural mesothelioma","volume":"462","author":"Hmeljak","year":"2013","journal-title":"Virchows Arch"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T11:14:01Z","timestamp":1646219641000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2020.11505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":44,"URL":"https:\/\/doi.org\/10.3892\/ol.2020.11505","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]}}}